Pharmacovigilance in USA and Canada is run by two regulators: the US FDA and Health Canada. In the US, companies report serious, unexpected adverse events to the FDA within 15 days and send periodic reports; since 1 October 2026, electronic case reports must use the ICH E2B(R3) format in the FDA’s Adverse Event Monitoring System (AEMS, formerly FAERS). In Canada, companies report serious reactions to the Canada Vigilance Program within 15 days and prepare an annual summary report, and since 2019 hospitals must also report serious reactions under Vanessa’s Law.
Key takeaways
- Regulators: US FDA (AEMS, formerly FAERS) and Health Canada (Canada Vigilance Program).
- Both countries use a 15-day clock for serious adverse reaction reports from companies.
- FDA made E2B(R3) mandatory for postmarketing case reports from 1 October 2026.
- Canadian hospitals must report serious reactions within 30 days (Vanessa’s Law, since 2019).
- Working in the US or Canada needs local work rights; Indian teams also serve these markets remotely.
Pharmacovigilance in USA and Canada: the basics
1What is pharmacovigilance?
Pharmacovigilance is the work of finding, checking, understanding and preventing side effects and other problems with medicines. That is how the World Health Organization defines it. The goal is simple: keep patients safe when they use medicines and vaccines.
2Who regulates drug safety in the USA and Canada?
In the USA, the Food and Drug Administration (FDA). In Canada, Health Canada, through its Marketed Health Products Directorate and the Canada Vigilance Program.
3Why does regulatory knowledge matter in PV jobs?
Every case, deadline and report follows a rule. PV staff must know what to report, to whom and how fast. These rules change often. Employers expect you to know the ICH E2 guidelines and the main FDA, EMA and Health Canada rules.
Drug safety rules in the USA
4What is FDA AEMS (formerly FAERS)?
It is the FDA’s database of side-effect reports for drugs and biologics. It used to be called FAERS. Its new name is the FDA Adverse Event Monitoring System (AEMS). Companies send case reports online. Doctors and patients can report through MedWatch.
5What are the US reporting timelines for marketed drugs?
US rule 21 CFR 314.80 sets two kinds of report. 15-day “alert reports” cover events that are both serious and unexpected. Periodic reports go every three months for the first three years after approval, then once a year.
6What changed with E2B(R3) in 2026?
From 1 October 2026, case reports for marketed drugs must use the ICH E2B(R3) format. They go through the FDA’s new online gateway. The older E2B(R2) format was accepted only until 30 September 2026.
7What about adverse events in US clinical trials?
Sponsors report serious, unexpected reactions seen in trials. Fatal or life-threatening ones go within 7 days. Others go within 15 days. This follows ICH E2A. Since 1 April 2026, these trial reports must also use the E2B(R3) format.
Drug safety rules in Canada
8What is the Canada Vigilance Program?
It is Health Canada’s safety-watch program for products on sale. It collects and reviews reports of suspected side effects. Reports come from companies, doctors and the public.
9What are the Canadian reporting timelines for companies?
Rule C.01.017 gives companies 15 days to report two kinds of case. The first is any serious reaction in Canada. The second is a serious, unexpected reaction outside Canada.
10What is an annual summary report in Canada?
Rule C.01.018 asks companies to review the side effects of each drug once a year, and whenever Health Canada asks. If the balance of benefit and risk changes a lot, they must tell Health Canada at once.
11What is Vanessa’s Law?
It is a 2014 law to protect Canadians from unsafe drugs. Since 16 December 2019, hospitals must report serious drug reactions and device problems to Health Canada. They have 30 days from when they first record them.
USA (FDA)
- Safety database
- AEMS (formerly FAERS)
- Company expedited reports
- 15-day alert reports (serious + unexpected)
- Periodic reports
- Quarterly for 3 years, then yearly
- Clinical trial safety
- 7 / 15 days (IND rules)
- Hospital reporting
- Voluntary (MedWatch)
Canada (Health Canada)
- Safety database
- Canada Vigilance Program
- Company expedited reports
- 15 days (domestic serious; foreign serious unexpected)
- Periodic reports
- Annual summary report
- Clinical trial safety
- 7 / 15 days (C.05.014)
- Hospital reporting
- Mandatory within 30 days (Vanessa’s Law)
Pharmacovigilance jobs in the USA and Canada
12What pharmacovigilance roles exist?
Common roles include:
- Drug Safety Associate / Case Processing Specialist
- Drug Safety Scientist or Specialist
- Aggregate (periodic) Report Specialist
- Signal Management Specialist
- Risk Management Specialist
- PV Quality and Compliance / Auditor
- Safety Physician (for doctors)
- MedDRA Coder
- PV Systems and Validation Specialist
13Do I need a medical degree?
Not for most roles. Pharmacy, life science and nursing graduates commonly work in case processing, reports and quality. Safety physician roles need a medical degree and, usually, a local licence.
14Can I work in US or Canadian PV from India?
Yes, in a way. Many drug firms, CROs and IT firms have drug-safety teams in India. These teams handle cases for the US and Canada. Moving abroad is different. You need a work permit or visa, which depends on the employer and local rules. BCRI does not promise jobs abroad.
See how roles grow in our pharmacovigilance career path guide, with Indian salary data.
Training for pharmacovigilance in USA and Canada
15Does BCRI’s pharmacovigilance course cover US and Canadian rules?
Yes. Our Pharmacovigilance Training (2 months, ₹22,500) covers ICH E2 guidelines and the main FDA, EMA and other regulatory requirements, with hands-on case processing on a safety database and MedDRA coding. Classes are live online — open to learners abroad — or at HSR Layout, Monday to Friday.
16Can I get practical experience?
Yes. BCRI offers a standalone pharmacovigilance internship, online or at our Bangalore centre. It is paid; your advisor shares the current fee and duration. You receive a BCRI certificate and a letter.
17Which other courses help?
PV Database Training (20 hours) for hands-on safety-database skills, and Advanced Regulatory Affairs (1.5 months, online) for drug-safety regulations.
FAQs
Is pharmacovigilance a good career in the USA and Canada?
Drug safety is required by law in both countries, so companies always need PV staff. Competition and work-permit rules vary, so many Indian graduates start in Indian PV teams that serve these markets.
What is the 15-day rule in pharmacovigilance?
Both the FDA (21 CFR 314.80) and Health Canada (C.01.017) require companies to report qualifying serious adverse reactions within 15 days of learning about them.